# q04 rev 2 - blind solver B (raw, verbatim)

- Date: 2026-10-06. Fresh blind-solver agent (claude-opus-5-5, scope hook), given only the
  workspace root, the solver-2 packet path and the question. Copied verbatim from the task
  notification.
- tested_sha256: 0642033f48a4f31d6e03ff05ecf695cb3791cecd20aee2372d093ec7988fcba8

## Return

I found no reported figure for the twelve months ended June 30, 2026, so I built it from four quarters on the recast basis (2026 segment definition). The result is **20.33%**.

answer: 20.33%

confidence: high

path:
1. **Which definition applies.** D11 line 85 says the structure takes effect "for the quarter ended March 31, 2026". It also says "the skin health business (previously within the North America reportable operating segment)" was moved into the new Europe, Middle East &amp; Africa segment. D12 Table 5 note (1) says "The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026." D10 is the "Segment Information (Recast)" exhibit, which restates 2025 on that basis.
2. **Q3 2025 (D10 line 312, three months ended September 30, 2025).** "North America | $ 922 | $ 381 | $ 342 | $ (1) | $ 199". Net sales 922, operating profit 199.
3. **Q4 2025 (derived from D10).** The full-year 2025 row (line 25) is "North America | $ 3,679 | … | $ 790". The nine-month row (line 333) is "$ 2,745 | … | $ 583". So Q4 net sales = 3,679 − 2,745 = 934, and operating profit = 790 − 583 = 207. I checked these rows against the original file docs/cl_ex991_2026-03-17.txt and they match.
4. **Q1 2026 (D11 Table 4, lines 369 and 385).** North America net sales "$ 888 | $ 904", operating profit "$ 141 | $ 197".
5. **Q2 2026 (D12 Table 5, lines 428 and 444).** "North America(1) | $ 891 | $ 919 | $ 1,779 | $ 1,823" for net sales and "$ 192 | $ 187 | $ 333 | $ 384" for operating profit. The 2025 comparatives there (919/187 and 1,823/384) match D10's recast figures. The six-month 2026 totals equal Q1 plus Q2: 888 + 891 = 1,779 and 141 + 192 = 333.
6. **Twelve-month totals.**
   - Net sales: 922 + 934 + 888 + 891 = 3,635.
   - Operating profit: 199 + 207 + 141 + 192 = 739.
   - Cross-check (full year 2025 − first half 2025 + first half 2026): net sales 3,679 − 1,823 + 1,779 = 3,635; operating profit 790 − 384 + 333 = 739. Both methods agree.
7. **Margin.** 739 / 3,635 = 0.203301, which is 20.33%.
8. **Impairment check.** The fourth-quarter 2025 skin-health impairment ($919) sits in Corporate, not in the segment (D09 line 491: "Corporate Operating profit (loss) for the three months ended December 31, 2025 included goodwill and intangible assets impairment charges of $919"). It does not change North America's operating profit.

minimal_documents: D10 + D12. D10 gives the recast full year 2025; D12 gives both first halves and the recast note. D10 cannot be replaced, because the recast Q3/Q4 2025 and full-year 2025 figures appear only there. D11 is optional: it supplies Q1 2026 (also derivable from D12) and the explicit description of the realignment.

readings:
- **Mixed basis (mistaken).** Using the figures originally reported for Q3/Q4 2025 under the old definition: D08 line 419 gives 999 net sales and line 436 gives 190 operating profit; D09 lines 460 and 477 give 1,021 and 203. Adding first-half 2026 (1,779 / 333) gives 3,799 net sales and 726 operating profit, or 19.11%. This contradicts "as the company defined that segment from 2026" and mixes two definitions.
- **Average of the four quarterly margins (not standard).** The quarters are 21.58%, 22.16%, 15.88% and 21.55%, averaging 20.29%. A sales-weighted ratio (20.33%) is the usual way to state a twelve-month margin.

gaps:
- **No direct figure.** No document reports twelve months ended June 30, 2026, so the answer is computed. Q4 2025 is derived by subtraction.
- **Rounding.** All inputs are rounded to millions ("Table may not sum due to rounding"). Rebuilding Q4 2025 from D10's cost lines gives 208 instead of 207, which would make the margin 20.36%. D11 prints the Q1 2026 margin as 15.8%, while 141/888 is 15.88%, which shows the underlying unrounded figures differ slightly. At two decimals the answer therefore depends on reported rounding; 20.33% follows from the reported operating profit rows.
- **Coverage.**
  - Read in full: D10, D11, D12.
  - Read in part: D08 (North America rows only) and D09 (North America rows, lines 60–139, impairment lines).
  - Not read beyond targeted searches: D01–D07, which cover older periods or the 2024 segment structure.
- **Extraction.** D10's Q1 2025 row was flattened in extraction ("North America $ 904 $ 358 $ 350 $ — $ 197") but is readable, and it matches the original and D11.

contaminated: no

Relevant files (packet root D:\Dev\Docket\tasks\aq-docket-trial-02\runs\q04-r2-v2-0642033f48a4f31d6e03ff05ecf695cb3791cecd20aee2372d093ec7988fcba8\solver-2):
- text\D10.txt
- text\D11.txt
- text\D12.txt
- docs\cl_ex991_2026-03-17.txt
